Scientists computationally restore the potency of an antibod

A team of researchers from the United States computationally modified the COV2-2130 monoclonal antibody to restore its neutralizing ability against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants, while retaining efficacy against the Delta and wild-type strains.

Related Keywords

United States , , Wa Hydrogen , Lab Diagnostics Automation , Lab Diagnostics Automation Industry , Automation Industry Focus , Antibody , Coronavirus Disease Covid 19 , Micron , Cars , Ars Cov 2 , Antibodies , Ntigen , Binding Affinity , Coronavirus , Covid 19 , Efficacy , Lisa , Immunity , Immunoassays , Machine Learning , Monoclonal Antibody , Utation , Pandemic , Eceptor , Espiratory , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome ,